Laboratorios Farmaceuticos Rovi, S.A. Share Price
Stocks
ROVI
ES0157261019
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.68 EUR | +0.30% |
|
-2.78% | -9.29% |
| 05-13 | Spanish stocks - Factors to watch on May 13 | RE |
| 05-09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
| Market Cap | 2.94B 3.35B 2.71B 2.52B 4.76B 318B 4.85B 32.56B 12.62B 156B 12.58B 12.31B 544B | P/E 2026 * |
22x | P/E 2027 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise Value | 2.91B 3.32B 2.68B 2.5B 4.71B 315B 4.81B 32.25B 12.5B 155B 12.46B 12.19B 539B | EV / Sales 2026 * |
3.76x | EV / Sales 2027 * | 3.18x |
| Free-Float |
31.63% | Yield 2026 * |
1.69% | Yield 2027 * | 1.95% |
Last Transcript: Laboratorios Farmaceuticos Rovi, S.A.
| 1 day | +0.30% | ||
| 1 week | -2.78% | ||
| Current month | -0.43% | ||
| 1 month | -0.43% | ||
| 3 months | -30.31% | ||
| 6 months | -9.08% | ||
| Current year | -9.29% |
| 1 week | 57.2 |  | 59.15 |
| 1 month | 57.2 | | 59.7 |
| Current year | 57.2 | | 86.7 |
| 1 year | 51.65 | | 86.7 |
| 3 years | 37.96 | | 94.8 |
| 5 years | 35.2 | | 94.8 |
| 10 years | 10.8 | | 94.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 26/07/2007 | |
| Director of Finance/CFO | - | 31/12/2000 | |
| Chief Tech/Sci/R&D Officer | - | 31/12/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 16/07/2021 | |
| Director/Board Member | - | 26/07/2007 | |
| Director/Board Member | - | 26/07/2007 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22/06/23 | Buy | Director | 1,000 | 0.0019% | ||
| 12/04/22 | Norbel Inversiones SL
| Sell | Company | 560,690 | 1.0000% | |
| 14/03/22 | Norbel Inversiones SL
| Sell | Company | 2,803,448 | 5.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.30% | -2.78% | +3.32% | +39.47% | 3.35B | |
| +3.09% | +9.12% | +57.91% | +166.70% | 1,063B | |
| +2.74% | +5.89% | +66.69% | +58.75% | 611B | |
| +3.44% | +5.99% | +35.10% | +90.87% | 444B | |
| +4.08% | -0.96% | +26.12% | +20.22% | 324B | |
| +5.83% | +3.37% | +39.90% | +40.12% | 285B | |
| +2.92% | +1.95% | +30.51% | +45.09% | 283B | |
| +2.63% | +5.29% | -24.72% | -38.60% | 219B | |
| +3.50% | +5.46% | +25.35% | +65.37% | 195B | |
| +3.98% | +5.17% | +16.80% | +69.78% | 156B | |
| Average | +3.23% | +2.22% | +27.70% | +55.78% | 358.4B | |
| Weighted average by Cap. | +3.37% | +4.15% | +41.45% | +83.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 774M 882M 712M 664M 1.25B 83.81B 1.28B 8.57B 3.32B 41.14B 3.31B 3.24B 143B | 898M 1.02B 827M 770M 1.45B 97.26B 1.48B 9.94B 3.85B 47.74B 3.84B 3.76B 166B |
| Net income | 133M 151M 122M 114M 215M 14.4B 219M 1.47B 570M 7.07B 569M 556M 24.6B | 178M 202M 163M 152M 287M 19.23B 293M 1.97B 762M 9.44B 760M 743M 32.85B |
| Net Debt | -27.87M -31.74M -25.65M -23.91M -45.09M -3.02B -46M -309M -120M -1.48B -119M -117M -5.16B | -85.9M -97.83M -79.07M -73.68M -139M -9.3B -142M -951M -368M -4.57B -367M -359M -15.89B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | €57.60 | +0.17% | 66,800 |
| 01/07/26 | €57.50 | -0.61% | 74,835 |
| 30/06/26 | €57.85 | -1.45% | 129,596 |
| 29/06/26 | €58.70 | +0.17% | 107,694 |
| 26/06/26 | €58.60 | -1.10% | 84,479 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ROVI Stock
Select your edition
All financial news and data tailored to specific country editions
